Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    Latent TB infection: updated and consolidated guidelines for programmatic management

    World Health Organization.
    Background The programmatic management of latent tuberculosis infection (LTBI) in populations most at risk of developing TB remains a critical activity to disrupt Mycobacterium tuberculosis transmission, as identified in the End TB Strategy. LTBI is defined as a state of persistent immune response to sti...
    Tuberculosis Latente/tratamiento farmacológico, Tuberculosis Latente/prevención & control, Tuberculosis Latente/diagnóstico, Trazado de Contacto, Medición de Riesgo, Algoritmos, Infecciones por VIH, Antituberculosos/administración & dosificación
    Texto completo

    Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

    Lewinsohn, DM; Leonard, MK; LoBue, PA; Cohn, DL; Daley, CL; Desmond, E; Keane, J; Lewinsohn, DA; Loeffler, AM; Mazurek, GH; O'Brien, RJ; Pai, M; Richeldi, L; Salfinger, M; Shinnick, TM; Sterling, TR; Warshauer, DM; Woods, GL.
    Clin Infect Dis.; 64 (2), 2017
    BACKGROUND: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality...
    Tuberculosis Pulmonar/diagnóstico, Tuberculosis Latente/diagnóstico, Sensibilidad y Especificidad, Mycobacterium tuberculosis/aislamiento & purificación, Tuberculosis/diagnóstico, Enfoque GRADE, Prueba de Tuberculina, Reproducibilidad de los Resultados, Ensayos de Liberación de Interferón gamma
    Texto completo

    Guidelines on the Management of Latent Tuberculosis Infection

    World Health Organization.
    The overall objective of the guidelines is to provide public health approach guidance on evidencebased practices for testing, treating and managing LTBI in individuals with the highest risk of progression to active disease. The guidelines are expected to provide the basis and rationale for the developmen...
    Antituberculosos/administración & dosificación, Tuberculosis Latente/tratamiento farmacológico, Tuberculosis Latente/prevención & control, Poblaciones Vulnerables, Resultado del Tratamiento, Cumplimiento de la Medicación, Rifampin/administración & dosificación, Isoniazida/administración & dosificación, Quimioterapia Combinada, Tuberculosis Latente/diagnóstico
    Texto completo (enlace principal)     Texto completo (enlace alternativo)     Texto completo (enlace alternativo)